Navigation

Skiplink Navigation

Main Features

Roche forges new diagnostic alliance

The Basel-based pharmaceuticals company, Roche, has formed an alliance with the US Millennium group to develop diagnostic products for rheumatoid arthritis.

Under the three-year deal, Millennium will receive a licensing fee, royalties and funding for research. Roche gets certain research and development rights and will market products resulting from the alliance.

"The combination of Roche's world-class strength in diagnostics with Millennium's strong position in genomics and proteomics will bring revolutionary diagnostic products to the market," said Heino von Prondzynski, the head of Roche's diagnostics division.

No financial details of the agreement have been released.

Swissinfo with agencies

Neuer Inhalt

Horizontal Line


subscription form

Form for signing up for free newsletter.

Sign up for our free newsletter and get the top stories delivered to your inbox.

swissinfo EN

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

Join us on Facebook!

×